Ruijin Hospital

This study tests a personalized treatment approach for people newly diagnosed with marginal zone lymphoma, a slow-growing blood cancer. Researchers will assign treatments based on each patient's risk level, aiming to improve cancer control and reduce side effects. About 145 adult…

This study is testing a combination of three drugs (orelabrutinib, selinexor, and either methotrexate or alternatives) in 25 people with relapsed or refractory central nervous system lymphoma (CNSL), a type of brain cancer that has not responded to prior treatment. The goal is to…

This early-phase study tests a new treatment called RXIM002 for people with severe autoimmune diseases that haven't responded to other therapies. RXIM002 uses a special RNA to create CAR T-cells inside the body that target and destroy faulty B-cells. The study will enroll 27 adul…

This study tests whether taking a low dose of colchicine (a medicine used for gout) every day for a year can help prevent the failure of bypass grafts in people who have had coronary artery bypass surgery. About 100 adults will be enrolled within 3 days after surgery and followed…

This study is testing an artificial intelligence (AI) system that can recognize different parts of the nose and throat and detect abnormal growths (lesions) from standard camera images. About 500 adults who undergo a routine nose-and-throat exam will have their images used to tra…